| First Author | Xue Q | Year | 2023 |
| Journal | PLoS Pathog | Volume | 19 |
| Issue | 7 | Pages | e1011511 |
| PubMed ID | 37410776 | Mgi Jnum | J:344745 |
| Mgi Id | MGI:7510679 | Doi | 10.1371/journal.ppat.1011511 |
| Citation | Xue Q, et al. (2023) NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3. PLoS Pathog 19(7):e1011511 |
| abstractText | The innate immune system is the first line of the host's defense, and studying the mechanisms of the negative regulation of interferon (IFN) signaling is important for maintaining the balance of innate immune responses. Here, we found that the host GTP-binding protein 4 (NOG1) is a negative regulator of innate immune responses. Overexpression of NOG1 inhibited viral RNA- and DNA-mediated signaling pathways, and NOG1 deficiency promoted the antiviral innate immune response, resulting in the ability of NOG1 to promote viral replication. Vesicular stomatitis virus (VSV) and herpes simplex virus type 1 (HSV-1) infection induced a higher level of IFN-beta protein in NOG1 deficient mice. Meanwhile, NOG1-deficient mice were more resistant to VSV and HSV-1 infection. NOG1 inhibited type I IFN production by targeting IRF3. NOG1 was also found to interact with phosphorylated IFN regulatory factor 3 (IRF3) to impair its DNA binding activity, thereby downregulating the transcription of IFN-beta and downstream IFN-stimulated genes (ISGs). The GTP binding domain of NOG1 is responsible for this process. In conclusion, our study reveals an underlying mechanism of how NOG1 negatively regulates IFN-beta by targeting IRF3, which uncovers a novel role of NOG1 in host innate immunity. |
